Albeit encouraging, this result is not predictive of any activity in GIST WT tumors, since these cell lines poorly express IGF1R, harbor KIT mutations and are dependent on aberrant KIT signaling for proliferation and survival. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.